Biased Usage of BV Gene Families of T-cell Receptors of WT1 (Wilms' Tumor Gene)-specific CD8+ T Cells in Patients with Myeloid Malignancies

Overview

Journal Cancer Sci

Specialty Oncology

Date 2010 Feb 6

PMID 20132220

Citations 14

Authors

Yukie Tanaka-Harada

Manabu Kawakami

Yoshihiro Oka

Akihiro Tsuboi

Takamasa Katagiri

Olga A Elisseeva

Sumiyuki Nishida

Toshiaki Shirakata

Naoki Hosen

Fumihiro Fujiki

Ayako Murao

Hiroko Nakajima

Yusuke Oji

Yoshinobu Kanda

Ichiro Kawase

Haruo Sugiyama

Affiliations

Soon will be listed here.

Abstract

WT1 (Wilms' tumor gene 1) protein is a potent pan-tumor-associated antigen (TAA) and WT1-specific cytotoxic T lymphocytes (WT1 tetramer(+) CD8(+) T cells) are spontaneously induced in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). We conducted a single-cell level comparative analysis of T-cell receptor beta-chain variable region (TCR-BV) gene families of a total of 1242 spontaneously induced WT1 tetramer(+) CD8(+) T cells in HLA-A*2402(+) patients with AML or MDS and those in healthy donors (HDs). This is the first report of direct usage analysis of TCR-BV gene families of individual TAA-specific CD8(+) T cells at single-cell level. Usage analysis using single-cell RT-PCR of TCR-BV gene families of individual FACS-sorted WT1 tetramer(+) CD8(+) T cells showed for the first time (i) that BVs 5, 6, 20, and 27 were commonly biased in both HDs and patients; (ii) that BV4 was commonly biased in HDs and MDS patients; (iii) that BV19 was commonly biased in the patients; and (iv) that BVs 7 and 28, BVs 9 and 15, and BVs 12 and 29 were specifically biased in HDs, AML, and MDS patients, respectively. However, statistical analysis of similarity among HD, AML, and MDS of individual usage frequencies of 24 kinds of TCR-BV gene families indicated that the usage frequencies of TCR-BV gene families in AML and MDS patients reflect those in HDs. These findings represent a novel insight for a better understanding of WT1-specific immune response.

Citing Articles

Decade-long WT1-specific CTLs induced by WT1 peptide vaccination.

Suwabe T, Shibasaki Y, Tamura S, Katagiri T, Fuse K, Ida-Kurasaki T Int J Hematol. 2024; 119(4):399-406.

PMID: 38427208 DOI: 10.1007/s12185-024-03723-1.

Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation.

Nakasone H, Kusuda M, Terasako-Saito K, Kawamura K, Akahoshi Y, Kawamura M Commun Biol. 2021; 4(1):1177.

PMID: 34635773 PMC: 8505416. DOI: 10.1038/s42003-021-02709-7.

Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients.

Xydia M, Rahbari R, Ruggiero E, Macaulay I, Tarabichi M, Lohmayer R Nat Commun. 2021; 12(1):1119.

PMID: 33602930 PMC: 7893042. DOI: 10.1038/s41467-021-21297-y.

Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial.

Shimizu Y, Yoshikawa T, Kojima T, Shoda K, Nosaka K, Mizuno S Cancer Sci. 2019; 110(10):3049-3060.

PMID: 31390678 PMC: 6778658. DOI: 10.1111/cas.14165.

WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.

Liu H, Zha Y, Choudhury N, Malnassy G, Fulton N, Green M Exp Hematol Oncol. 2018; 7:1.

PMID: 29344432 PMC: 5765712. DOI: 10.1186/s40164-018-0093-x.

References

Zhou J, Dudley M, Rosenberg S, Robbins P . Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma. J Immunol. 2004; 173(12):7622-9. PMC: 2174603. DOI: 10.4049/jimmunol.173.12.7622. View

Gao L, Bellantuono I, Elsasser A, Marley S, Gordon M, Goldman J . Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood. 2000; 95(7):2198-203. View

Champagne P, Ogg G, King A, Knabenhans C, Ellefsen K, Nobile M . Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 2001; 410(6824):106-11. DOI: 10.1038/35065118. View

Kalams S, Johnson R, Trocha A, Dynan M, Ngo H, DAquila R . Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med. 1994; 179(4):1261-71. PMC: 2191456. DOI: 10.1084/jem.179.4.1261. View

Polz M, Cavanaugh C . Bias in template-to-product ratios in multitemplate PCR. Appl Environ Microbiol. 1998; 64(10):3724-30. PMC: 106531. DOI: 10.1128/AEM.64.10.3724-3730.1998. View

Valmori D, Dutoit V, Schnuriger V, Pittet M, Guillaume P, Rubio-Godoy V . Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity. J Immunol. 2002; 168(8):4231-40. DOI: 10.4049/jimmunol.168.8.4231. View

Geursen A, Skinner M, Townsend L, Perko L, Farmiloe S, Peake J . Population study of T cell receptor V beta gene usage in peripheral blood lymphocytes: differences in ethnic groups. Clin Exp Immunol. 1993; 94(1):201-7. PMC: 1534351. DOI: 10.1111/j.1365-2249.1993.tb06001.x. View

Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim E . Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res. 1999; 90(2):194-204. PMC: 5926055. DOI: 10.1111/j.1349-7006.1999.tb00733.x. View

Gomi S, Nakao M, Niiya F, Imamura Y, Kawano K, Nishizaka S . A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs. J Immunol. 1999; 163(9):4994-5004. View

10.

Kasprowicz V, Isa A, Jeffery K, Broliden K, Tolfvenstam T, Klenerman P . A highly restricted T-cell receptor dominates the CD8+ T-cell response to parvovirus B19 infection in HLA-A*2402-positive individuals. J Virol. 2006; 80(13):6697-701. PMC: 1488968. DOI: 10.1128/JVI.02388-05. View

11.

Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki J, Iwama H, Inoue K . The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia. 1999; 13(3):393-9. DOI: 10.1038/sj.leu.2401341. View

12.

Mandruzzato S, Rossi E, Bernardi F, Tosello V, Macino B, Basso G . Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient. J Immunol. 2002; 169(7):4017-24. DOI: 10.4049/jimmunol.169.7.4017. View

13.

Tsuboi A, Oka Y, Ogawa H, Elisseeva O, Li H, Kawasaki K . Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination. J Clin Immunol. 2000; 20(3):195-202. DOI: 10.1023/a:1006637529995. View

14.

Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H . Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci U S A. 2004; 101(38):13885-90. PMC: 518848. DOI: 10.1073/pnas.0405884101. View

15.

Kumamaru W, Nakamura S, Kadena T, Yamada A, Kawamura E, Sasaki M . T-cell receptor Vbeta gene usage by T cells reactive with the tumor-rejection antigen SART-1 in oral squamous cell carcinoma. Int J Cancer. 2003; 108(5):686-95. DOI: 10.1002/ijc.11591. View

16.

Salvi S, Segalla F, Rao S, Arienti F, Sartori M, BRATINA G . Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer Res. 1995; 55(15):3374-9. View

17.

Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H . WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 1994; 84(9):3071-9. View

18.

Dietrich P, Walker P, Quiquerez A, Perrin G, Dutoit V, Lienard D . Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires. Cancer Res. 2001; 61(5):2047-54. View

19.

Burrows S, Silins S, Cross S, A Peh C, Rischmueller M, Burrows J . Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire. Eur J Immunol. 1997; 27(1):178-82. DOI: 10.1002/eji.1830270126. View

20.

Valmori D, Dutoit V, Lienard D, Lejeune F, Speiser D, Rimoldi D . Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. J Immunol. 2000; 165(1):533-8. DOI: 10.4049/jimmunol.165.1.533. View